BioCentury
ARTICLE | Clinical News

Tamogel: Phase II

December 15, 2003 8:00 AM UTC

In a French Phase II trial comparing Tamogel to oral tamoxifen or no therapy in 51 patients, Tamogel use for 2-3 weeks prior to surgery reduced tumor tissue proliferation in a dose-dependent manner an...